Literature DB >> 9086882

Cerebral perfusion defects secondary to simple craniosynostosis.

L R David1, J A Wilson, N E Watson, L C Argenta.   

Abstract

Premature fusion of multiple cranial sutures has been associated with increased intracranial pressure and the potential for mental impairment. Isolated craniosynostosis, however, has been thought to be a benign condition primarily reconstructed for aesthetic purposes. On the basis of subjective developmental improvement postoperatively, an objective radiographic analysis (single positron emission computed tomography [SPECT] was used to assess differences in cerebral perfusion in the areas compressed secondary to the fused cranial suture both before and after cranial reconstructive surgery in patients with simple craniosynostosis. Seven children with craniosynostosis, six boys and one girl (age age, 3-28 months), were enrolled in this prospective study. Six of the seven had cranial asymmetry on preoperative cranial computed tomographic scans, and one had a symmetric defect and was used as a control. Each subject had a preoperative SPECT scan approximately 3 to 5 days before the cranial reconstruction procedure and a follow-up scan 6 to 10 weeks postoperatively. Preoperative asymmetries in cerebral perfusion ranged from 0 to 30% (mean, 13%) the areas compressed secondary to the premature suture fusion. In five patients cerebral blood flow, which was asymmetric before surgery, became symmetric after craniofacial reconstruction, and no new perfusion defects were documented. The control patient and one another patient had symmetric perfusion both pre- and postoperatively. Craniosynostosis may be associated with decreased cerebral blood flow as a result of the constriction of the brain from the prematurely fused suture. The correction of asymmetric cranial single-suture synostosis is more than a cosmetic procedure in that it allows for normalization of cerebral blood flow. This difference in blood flow supports early surgical intervention to prevent any potential central nervous system compromise secondary to abnormal blood flow.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9086882     DOI: 10.1097/00001665-199605000-00003

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  6 in total

1.  The Unnecessity of Positron Emission Tomography Computed Tomography in the Etiologic Evaluation of Neurodevelopmental Delay in Craniosynostosis Patients.

Authors:  Chae Eun Yang; Eun Kyung Park; Myung Chul Lee; Kyu Won Shim; Yong Oock Kim
Journal:  Arch Craniofac Surg       Date:  2017-03-25

2.  The influence of surgical correction on white matter microstructural integrity in rabbits with familial coronal suture craniosynostosis.

Authors:  Christopher M Bonfield; Lesley M Foley; Shinjini Kundu; Wendy Fellows-Mayle; T Kevin Hitchens; Gustavo K Rohde; Ramesh Grandhi; Mark P Mooney
Journal:  Neurosurg Focus       Date:  2015-05       Impact factor: 4.047

3.  Cerebral oxygenation and hemodynamic measurements during craniosynostosis surgery with near-infrared spectroscopy.

Authors:  M Martini; A Röhrig; M Wenghoefer; E Schindler; A M Messing-Jünger
Journal:  Childs Nerv Syst       Date:  2014-05-01       Impact factor: 1.475

4.  Cephalometric Features of Moyamoya Disease: A case control study.

Authors:  Adnan I Qureshi; Waqas I Gilani; Sarwat I Gilani; Malik M Adil
Journal:  J Vasc Interv Neurol       Date:  2014-11

5.  Age-related peridural hyperemia in craniosynostotic rabbits.

Authors:  Lesley M Foley; Wendy Fellows-Mayle; T Kevin Hitchens; Joseph E Losee; Timothy Barbano; Michael I Siegel; Mark P Mooney
Journal:  Childs Nerv Syst       Date:  2009-05-05       Impact factor: 1.475

6.  The influence of suturectomy on age-related changes in cerebral blood flow in rabbits with familial bicoronal suture craniosynostosis: A quantitative analysis.

Authors:  Ramesh Grandhi; Geoffrey W Peitz; Lesley M Foley; Christopher M Bonfield; Wendy Fellows-Mayle; T Kevin Hitchens; Mark P Mooney
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.